(124 days)
No
The summary describes a dental ceramic material and its manufacturing process, with no mention of AI or ML in the device description, intended use, or performance studies.
No.
This device is used in the manufacture of a dental core, which is a component of an artificial tooth. It is a ceramic material that is milled and then sintered to form the core, which then has porcelain layered on it. Its function is to be a structural component of a dental prosthetic, not to treat or cure a disease or condition, or affect the structure or function of the body in a therapeutic way.
No
This device is a material used in the manufacturing process of a dental core, which is a component of an artificial tooth. It is not used to diagnose a medical condition or disease.
No
The device description clearly states it is a "partially sintered dental ceramic made out of colored ZrO2(Y-TZP)" and describes its physical properties and manufacturing process, indicating it is a physical material, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "used in the manufacture of a dental core." This describes a material used in the creation of a medical device (a dental core/tooth), not a test performed on a biological sample to diagnose a condition.
- Device Description: The description details a material (partially sintered dental ceramic) that is processed and used to build a dental core. It doesn't describe a test kit, reagent, instrument, or software used for in vitro examination of specimens.
- Lack of Biological Sample Testing: There is no mention of the device being used to test blood, urine, tissue, or any other biological sample.
- Performance Studies: The performance studies focus on the material's properties (biocompatibility, strength, solubility, etc.) and manufacturing quality, not on diagnostic accuracy or performance in analyzing biological samples.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for diagnosis, monitoring, or screening. This device is a material used in the manufacturing process of a dental prosthesis.
N/A
Intended Use / Indications for Use
rainbow™ Trans is used in the manufacture of a dental core.
Product codes (comma separated list FDA assigned to the subject device)
EIH
Device Description
rainbow™ Trans is a partially sintered dental ceramic made out of colored ZrO2(Y-TZP). rainbow™ Trans is milled into cores of artificial teeth and then is finally sintered in a furnace to harden the ZrO2. Then, the core is layered with porcelain to make a finished tooth.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility testing on the proposed rainbow™ Trans has been completed. Requirements for biological evaluation of the proposed device were based on FDA recognized concensus standard of ISO10993, "Biological Evaluation of Medical Devices, Part 1: Evaluation and Testing." The biocompatibility test results show that the materials used in the design and manufacture of the components of the proposed device are non-toxic and non-sensitizing to biological bone and tissues with its intended use.
The proposed rainbow™ Trans was evaluated using the following performance bench testing to confirm the performance characteristics:
- Visual: No impurities and No specific changes
- Size: Size error of; Standard Size
§ 872.6660 Porcelain powder for clinical use.
(a)
Identification. Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized image of an eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle image. The logo is simple and recognizable, and it is often used on official documents and websites related to the department.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 28, 2015
Genoss c/o Mr. Dachan Kwon iCT America, Inc. 180 Sylvan Avenue, 2nd Floor Englewood Cliffs, New Jersey 07632
Re: K151723
Trade/Device Name: rainbow™ Trans Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder for Clinical Use Regulatory Class: II Product Code: EIH Dated: September 21, 2015 Received: September 23, 2015
Dear Mr. Kwon:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours, Tina Kiang
for Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Image /page/2/Picture/0 description: The image shows the word "GENOSS" in a stylized font. The letters "GENO" are in a dark green color, while the letters "SS" are in a lighter green shade. The font appears to be bold and sans-serif, with a slightly rounded design.
Indication for use
510(k) Number: K151723 rainbow™ Trans Device Name: rainbow™ Trans is used in the manufacture of a dental core. Indication for use:
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Indication for use
3
Image /page/3/Picture/1 description: The image shows the word "GENOSS" in a stylized font. The "GEN" part of the word is in a dark green color, while the "OSS" part is in a lighter green color. The font is sans-serif and has a modern look.
510(K) Summary
1. Company
| Submitter | |
|---|---|
| Name | GENOSS Co., Ltd. |
| Address | 1F, Gyeonggi R&DB Center / 226, 2F, GSBC, 105 |
| Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea | |
| Phone/Fax | +82-70-7098-8806/ +82-31-888-5595 |
| Contact person | Byungsun Kim / RA |
| bskim@genoss.com | |
| Summary Date | 10/16/2015 |
2. Device Identification
| Proprietary name | : | rainbow™ Trans |
|---|---|---|
| Regulation number | : | 21 CFR 872.6660 |
| Classification name | : | Porcelain powder for clinical use |
| Product code | : | EIH |
| Device class | : | Class II |
3. Predicate Device
| K092513 | Predicate |
|---|---|
| K093560 | Reference |
4. Description
rainbow™ Trans is a partially sintered dental ceramic made out of colored ZrO2(Y-TZP). rainbow™ Trans is milled into cores of artificial teeth and then is finally sintered in a furnace to harden the ZrO2. Then, the core is layered with porcelain to make a finished tooth.
4
Image /page/4/Picture/1 description: The image shows the word "GENOSS" in a stylized font. The letters "GENO" are in a dark green color, while the letters "OSS" are in a lighter green color. The font is sans-serif and has a modern look.
5. Indication for use
rainbow™ Trans is used in the manufacture of a dental core.
6. Comparison of Technological Characteristics
rainbow™ Trans has the similar technological characteristics as the predicate device; main material, indication for use and design. Technological characteristics of rainbow™ Trans, RAINBOW BLOCK, Upcera Zirconia Blanks are as following
| Device name | rainbowTM Trans | RAINBOW BLOCK | Upcera Zirconia Blanks |
|---|---|---|---|
| Manufacturer | Genoss Co., Ltd. | Genoss Co., Ltd. | Shenyang Upcera Co., Ltd. |
| 510(k) Number | New Device | K092513 | K093560 |
| Materials | ZrO2(3Y-TZP*) |
- 3Y-TZP : 3mol% Yttria Tetragonal
Zirconia Polycrystal | ZrO2(3Y-TZP*) | ZrO2(3Y-TZP*) |
| Form | Preformed block | Preformed block | Preformed block |
| Sterilization | Non-sterile | Non-sterile | Non-sterile |
| Indication for use | rainbowTM Trans is used in
the manufacture of a dental
core. | Rainbow Block is used in
the manufacture of a
dental core through
milling by machine
(MAD/MAM or
CAD/CAM) followed by
sintering. | Upcera Zirconia
Blanks are intended for
use in the production
of artificial teeth in fixed
or removable dentures,
or for jacket crowns,
facings, and veneers. |
| Use | Prescription | Prescription | Prescription |
| Properties | | | |
| Bending Strength
(Flexural strength) | 902MPa | 1144MPa | 1200MPa |
| Sintering Density
(g/cm3) | 6.006.04 | 6.006.04 | 6 |
| Radioactivity
(Bq/g) | 0.01 | 0.01 | 0.015 |
| Chemical Solubility
(µg/cm²) | 9 | 14.47 | 17.00 |
| Biocompatibility | Biocompatible | Biocompatible | Biocompatible |
The Indication for use and material of subject device and predicate device are equivalent. And the differences of technological characteristics(Flexural strength, chemical solubility) are within what is expected of this type of device. According to the standard ISO 6872:2008, both
510(k) Summary
5
Image /page/5/Picture/1 description: The image shows the word "GENOSS" in a stylized font. The letters "GENO" are in a dark green color, while the letters "SS" are in a lighter green color. The font is sans-serif and has a modern look.
subject device and predicate device are classified as Type II Class 6 dental ceramic indicated for prostheses involving four or more units, and both devices satisfy the mechanical and chemical properties(Flexural strength: ≥ 800MPa, Chemical solubility: ≤ 100ug/cm²). Therefore, the subject device is substantially equivalent to the predicate devices.
7. Performance Data
Biocompatibility testing on the proposed rainbow™ Trans has been completed. Requirements for biological evaluation of the proposed device were based on FDA recognized concensus standard of ISO10993, "Biological Evaluation of Medical Devices, Part 1: Evaluation and Testing." The biocompatibility test results show that the materials used in the design and manufacture of the components of the proposed device are non-toxic and non-sensitizing to biological bone and tissues with its intended use. The following biocompatibility tests were completed:
| No. | Items | Criteria | Result | Standard |
|---|---|---|---|---|
| 1 | Cytotoxicity | None cytotoxicity | None cytotoxicity | ISO 10993-5 |
| 2 | Sensitization | |||
| (Local Lymph Node Assay) | None sensitization | None sensitization | ISO 10993-10 | |
| 3 | Oral mucosa irritation | Less than stimulus | ||
| threshold | Minimal irritation | ISO 10993-10 | ||
| 4 | Acute systemic toxicity | None acute Systemic | ||
| toxicity | None acute Systemic | |||
| toxicity | ISO 10993-11 | |||
| 5 | Genotoxicity | None genotoxicity | None genotoxicity | ISO 10993-3 |
The proposed rainbow™ Trans was evaluated using the following performance bench testing to confirm the performance characteristics:
| No. | Items | Criteria | Result | Standard |
|---|---|---|---|---|
| 1 | Visual | No impurities | ||
| and No specific changes | No impurities | |||
| and No specific changes | ISO 6872 | |||
| 2 | Size | Size error of; | ||
| Standard Size |